Adam Knight, PhD
Go-getter · DISC type dAdam Knight is a venture capitalist and scientist, currently serving as Co-founder and Partner at Neuro. VC. He founded Neuron23, a clinical-stage biotech company, raising over $300M and leading it for over five years. He holds a PhD from the University of Cambridge and began his research career at The University of Alabama.
Adam is passionate about advancing treatments for neurodegenerative diseases, a journey that started nearly two decades ago. He is deeply supportive of his family, particularly celebrating the entrepreneurial success of his twin brother, Robby Knight. Adam draws inspiration from his personal experiences growing up in Alabama.
He founded Neuron23 just two years after completing his PhD, successfully building it into a clinical-stage company.
Read the full overview →How Adam shows up
They care equally about the product and its potential impact. They focus on objectivity in a pitch and pay little attention to bells and whistles. They can be nudged to make faster decisions by offering what they value.
Topics Adam cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.